Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06353087 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06353087 · ClinicalTrials.gov record · last posted 2026-08-18

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

Name: Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) — clinical trial record (NCT06353087)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ATTRACT

StatusCompleted

PhaseNot specified

SponsorPfizer

Started2024-06-19

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study is to describe the real-world treatment patterns and clinical outcomes in moderate-to-severe AD patients receiving abrocitinib over a 12-month observation period, and to describe patient demographic and baseline characteristics.

Protocol amendment history 3 changes detected by DataLookout

2026-08-19

Trial completed

2026-08-19

Primary completion moved earlier: 2027-01-30 → 2026-06-22

2026-08-19

Completion moved earlier: 2027-01-30 → 2026-06-22

Trial Details

NCT Number	NCT06353087
Lead Sponsor	Pfizer
Conditions	Dermatitis, Atopic, Dermatitis, Eczema, Skin Diseases, Immune System Diseases, Janus Kinase Inhibitors
Enrollment	41 participants
Start Date	2024-06-19
Primary Completion	2026-06-22 (estimated)
Study Completion	2026-06-22 (estimated)
Updated on ClinicalTrials.gov	2026-08-18